Professional manufacturer of Rifampicin and Rifamycin Derivatives. Rifamycin S Sodium, Rifamycin S, Rifampicin, Rifandine, Rifaximin, Rifampin producer supplier exporter
CPHI China 2025: Meet Hebei Xingang Pharmaceutical at Booth W7A15
Event Details:
Date: June 24-26, 2025
Location: Shanghai New International Expo Center (Pudong)
Booth: W7A15
Hebei Xingang Pharmaceutical Co Ltd, a globally recognized leader in rifamycin series products and anti-tuberculosis (TB) APIs, will showcase its cutting-edge pharmaceutical solutions at the 23rd China International Pharmaceutical Ingredients Exhibition (CPHI China 2025). As a trusted partner to formulation manufacturers worldwide, the company invites industry professionals to explore its high-quality intermediates, advanced production capabilities, and commitment to global health innovation.
Why Visit Hebei Xingang Pharmaceutical at Booth W7A15?
1. Premium Rifamycin APIs & Intermediates
Specializing in rifampicin, rifapentine, rifaximin, and rifabutin, Hebei Xingang Pharmaceutical supplies critical ingredients for:
Tuberculosis (TB) treatment
Broad-spectrum antibiotic formulations
Gastrointestinal health products
Their product portfolio meets stringent pharmacopeia standards (BP/EP/USP) and serves clients in 50+ countries, including India, Germany, Brazil, and Africa.
2. State-of-the-Art Manufacturing & Compliance
WHO GMP Certified: Validated by global health authorities, ensuring compliance with international quality benchmarks.
Advanced Facilities:
Computer-controlled fermentation and extraction workshops.
Separate production lines for API synthesis, minimizing cross-contamination risks.
Oil-free air compressors and closed vacuum systems for ultra-pure output.
3. Decades of Expertise & Innovation
Since 1996, the company has pioneered rifamycin biotechnology fermentation and built a reputation as a high-tech enterprise with:
Provincial-level R&D projects and patented fermentation optimizations.
In-house microbial labs with stainless steel fermentation tanks and modern testing instruments.
Global Reach, Local Expertise
Hebei Xingang Pharmaceutical’s products are trusted by leading pharmaceutical companies across:
Asia: India, Indonesia, Vietnam
Europe: Germany, Russia
Americas: Chile, Brazil
Africa: Key markets in TB-endemic regions
Their dedicated international sales team provides rapid response to regulatory audits, quality certifications, and supply chain inquiries.
Visit Booth W7A15 for:
Live demos of rifamycin S-Na salt and 3-F intermediates.
Discussions on custom synthesis and scalable API production.
Partnerships with a 20+ year industry veteran in anti-infective solutions.
Hebei Xingang Pharmaceutical's Rifampicin Achieves WHO Approval
On June 9, 2025, the WHO announced that Hebei Xingang's Rifampicin API meets the highest standards for quality, safety, and manufacturing, marking its official entry into the WHO market to combat tuberculosis globally.
This achievement rests on three critical foundations: the WHO's rigorous Prequalification program, universal Good Manufacturing Practices, and the vital role of Rifampicin.
🛡️
WHO Prequalification
A global benchmark for medicine quality, safety, and efficacy. The WHO-PQ program ensures that essential medicines meet stringent international standards, building trust in global supply chains.
🏭
GMP for APIs
The gold standard for pharmaceutical manufacturing. Good Manufacturing Practices ensure that Active Pharmaceutical Ingredients (APIs) are produced consistently and safely, minimizing all risks.
💊
Rifampicin's Role
A cornerstone antibiotic in the global fight against tuberculosis. Quality-assured Rifampicin is critical for effective treatment, preventing drug resistance, and saving lives.
The Path to Prequalification
Achieving WHO-PQ is an exhaustive process that validates every aspect of a product's lifecycle. Click each step to learn more about this rigorous journey.
1. Dossier Assessment
→
2. GMP Site Inspection
→
3. Quality Control Testing
→
4. Final Approval
Select a step above to see the details.
Global Impact & Significance
This approval has far-reaching consequences, from strengthening supply chains to improving patient outcomes worldwide.
Context: The Global Fight Against TB
Tuberculosis remains a major global health challenge. The availability of quality-assured medicines like Rifampicin is a critical component of the WHO's strategy to combat priority diseases.
A Threefold Victory for Public Health
✓
Combats Drug Resistance
Ensures effective first-line treatments are available, preventing the rise of deadly drug-resistant TB strains.
✓
Strengthens Supply Chains
Diversifies the pool of prequalified manufacturers, enhancing the resilience and reliability of global medicine supply.
✓
Improves Patient Outcomes
High-quality medicines directly translate to better treatment results and reduced mortality from tuberculosis.
Hebei Xingang Pharmaceutical: A Commitment to Excellence
This achievement is the result of an unwavering dedication to quality at every level of the organization.
📈
Robust Quality Systems
Implementing comprehensive systems that govern every aspect of operations, from raw material sourcing to final product release.
🔬
Advanced Facilities
Investing in state-of-the-art manufacturing facilities designed to prevent contamination and ensure optimal, consistent production.
👩🔬
Skilled Workforce
Employing a highly trained and competent team dedicated to upholding the most stringent GMP and international quality standards.
Hebei Xingang Pharmaceutical: WHO-PQ & GMP Approved Rifampicin for Global Health
🎉 OFFICIAL ANNOUNCEMENT: June 9, 2025, 3:52 PM - WHO Approves Hebei Xingang Pharmaceutical's Rifampicin for Global Market Entry
Hebei Xingang Pharmaceutical
WHO-PQ & GMP Approved Rifampicin for Global Health Excellence
Hebei Xingang Pharmaceutical's Rifampicin Achieves WHO-PQ and GMP Approval
A Landmark Achievement in Pharmaceutical Quality
Breaking News: The World Health Organization has officially confirmed that Hebei Xingang Pharmaceutical Co Ltd's Rifampicin meets all WHO Prequalification standards and Good Manufacturing Practices for Active Pharmaceutical Ingredients, marking a historic milestone in global pharmaceutical excellence.
Introduction
In a significant development for global public health, on June 9, 2025, at 3:52 pm, the World Health Organization (WHO) officially announced that Hebei Xingang Pharmaceutical Co Ltd's Rifampicin has successfully met the stringent WHO Prequalification (WHO-PQ) standards and is fully compliant with the principles of Good Manufacturing Practices (GMP) for Active Pharmaceutical Ingredients (APIs). This monumental achievement not only underscores Hebei Xingang Pharmaceutical's unwavering commitment to producing high-quality pharmaceutical products but also marks its official approval to enter the crucial WHO market.
WHO-PQ
Prequalification Achieved
GMP
Compliance Certified
2025
Year of Approval
Global
Market Access
Understanding WHO-PQ Standards
The WHO Prequalification (WHO-PQ) program is a comprehensive United Nations program established to ensure that health products procured by international agencies for developing countries meet acceptable standards of quality, safety, and efficacy. This rigorous assessment process involves a detailed evaluation of product quality, manufacturing site inspections, and laboratory testing. For a pharmaceutical product like Rifampicin to achieve WHO-PQ status, it must demonstrate consistent adherence to international norms, standards, and guidelines throughout its development and production lifecycle.
Adherence to Good Manufacturing Practices (GMP) for APIs
Good Manufacturing Practices (GMP) are a system of quality assurance that ensures products are consistently produced and controlled according to quality standards. For Active Pharmaceutical Ingredients (APIs), GMP compliance is particularly critical as APIs are the biologically active components of a drug product. The stringency of GMP in API manufacturing increases progressively from early synthesis steps to final purification and packaging, reflecting the escalating risk associated with each stage of production.
The Importance of Rifampicin in Global Health
Rifampicin, also known as rifampin, is a cornerstone antibiotic in the fight against several severe bacterial infections, most notably tuberculosis (TB) and certain forms of meningitis. As a potent ansamycin antibiotic, it plays a critical role in multi-drug regimens for TB, a disease that continues to be a major global health challenge. Its efficacy in killing or preventing the growth of various bacteria, including Mycobacterium tuberculosis and Neisseria meningitidis, makes it an indispensable medicine.
Hebei Xingang Pharmaceutical's Commitment to Quality and Innovation
Hebei Xingang Pharmaceutical Co Ltd has consistently demonstrated a profound commitment to quality, innovation, and continuous improvement within the pharmaceutical industry. This recent WHO-PQ and GMP approval for Rifampicin is not an isolated event but rather a reflection of the company's deeply ingrained philosophy of excellence. The company invests significantly in research and development, constantly seeking to enhance its manufacturing processes, optimize product formulations, and explore new therapeutic applications for its active pharmaceutical ingredients.
Future Implications and Market Entry
The official approval of Hebei Xingang Pharmaceutical Co Ltd's Rifampicin for entry into the WHO market signifies a pivotal moment for the company and for global health. This endorsement by the World Health Organization opens doors to new opportunities, allowing Hebei Xingang Pharmaceutical to significantly expand its reach and impact. The WHO-PQ status enables procurement agencies, non-governmental organizations, and national health programs worldwide to confidently source Rifampicin from Hebei Xingang, knowing it meets the highest international quality standards.
Partner with Excellence
Join us in our mission to provide world-class pharmaceutical solutions that meet the highest international standards.
The official announcement by the World Health Organization on June 9, 2025, at 3:52 pm, confirming Hebei Xingang Pharmaceutical Co Ltd's Rifampicin compliance with WHO-PQ and GMP standards, marks a significant milestone in the pharmaceutical industry. This achievement not only validates the company's unwavering dedication to producing high-quality Active Pharmaceutical Ingredients but also reinforces its crucial role in global health. By ensuring that Rifampicin, a vital antibiotic for treating tuberculosis and preventing meningitis, meets the most rigorous international benchmarks, Hebei Xingang Pharmaceutical is directly contributing to improved public health outcomes worldwide.
Hebei Xingang Pharmaceutical Co Ltd is located on the bank of the world-famous Zhaozhou Bridge – Zhaoxian Industrial Park, Shijiazhuang City, Hebei Province. It is adjacent to the Qingyin Expressway and National Highway 308 in the east, and the Beijing-Zhuhai Expressway and National Highway 107 in the west; it is 30 kilometers away from Shijiazhuang High-speed Railway Station and 50 kilometers away from Shijiazhuang International Airport. The company mainly engages in the research, development, production and sales of rifamycin biotechnology fermentation and pharmaceutical intermediates, APIs and related products. The main products are rifamycin S-Na salt, rifamycin S, 3-F, rifamycin SV sodium, rifampicin, rifapentine, rifaximin, rifabutin, rifaprodin and other rifamycin series products, as well as limonene and intermediates and more than ten varieties. It is one of the world’s major manufacturers of anti-tuberculosis APIs and rifamycin extended products.
Hebei Xingang Pharmaceutical Co., Ltd. was established in 1996. At the beginning of its establishment, the company clearly positioned its development goals: to strive to be the global leader in rifamycin series products and to devote itself to pursuing high-quality rifamycin series products. Under this goal orientation, the company firmly established the concept of “employee quality is the life of the enterprise, product quality is the global market”. Technical excellence stems from high morality. The high professional ethics of the company’s employees are the source of enterprise development. Xingang people are always full of vigorous spirit of pursuing excellence! They never stop self-cultivating noble sentiments! They cultivate their own lofty moral character with down-to-earth attitude! They always pursue and dedicate their excellent skills!
An excellent talent team creates high-quality products and promotes enterprise upgrading. The company has always placed product quality in the first place for global users’ peace of mind and comprehensively improved the quality assurance system. In 2004, the company introduced rifampicin and rifapentine APIs, and passed the Chinese GMP certification for the first time in the same year; in 2010, it passed the domestic GMP certification for the second time; in 2015, it successfully passed the new version of Chinese GMP certification.
The company has world-class production equipment and workshops, modern laboratories and testing facilities. The fermentation workshop has realized computer temperature control, automatic feeding, and fermentation equipment is closer to the international advanced level. The extraction workshop has been continuously advancing in the extraction process of rifamycin S sodium through continuous exploration and practice over the years, and product quality has been continuously improved. It not only improves production efficiency, improves production environment, but also improves product quality. The synthesis workshop has been updated with equipment and production line transformation. At present, it has two completely independent production lines, with separate human flow and material flow, effectively avoiding the risk of product confusion. The air conditioning pressure difference in the workshop clean area is automatically controlled by computer. Both lines are equipped with a fully enclosed vacuum feeding system, which greatly improves the working environment of workers, and fundamentally eliminates the intrusion of foreign objects, thereby greatly improving product quality. The newly purchased Atlas oil-free screw air compressor fundamentally eliminates the pollution caused by oil and water in compressed air to products.
Since its establishment, the company has always paid continuous attention and investment to R&D, and established long-term close contacts with many higher education institutions and scientific research institutions. The company was rated as a high-tech enterprise in 2012, and at the same time, the company’s technology center undertook a number of provincial and municipal scientific research projects in recent years, and achieved a number of scientific and technological achievements. The company adheres to the corporate development purpose of “the leader of rifamycin series products”, takes independent innovation as the source of enterprise development, continuously strengthens scientific and technological innovation, and promotes the transformation of achievements. The company has a domestic advanced microbial fermentation laboratory, which currently has three stainless steel fermentation tanks, one steam generator, as well as a self-control system and various modern testing instruments. The company’s R&D personnel have many years of laboratory R&D experience, and promote the comprehensive improvement of the company’s fermentation level through continuous optimization experiments on production strains. The company has always adhered to the corporate spirit of “product quality is the global market”, putting quality first. At present, the company has four laboratories, namely: fermentation central control room, synthesis central control room, east factory area laboratory and west factory area central laboratory.
All along, our company has pursued the concept of “enterprise development, environmental protection first”, and has made a lot of investment in environmental governance over the past ten years, providing a guarantee for the sustainable development of the enterprise. We always run through the concept of clean production throughout the production process, first of all, improve the system, conduct full staff training on clean production related knowledge, mobilize employees to brainstorm, actively propose improvement plans, and achieve “clean production, everyone is responsible”. All along, the company has been paying attention to the dynamics of environmental protection field, ready to introduce advanced environmental protection facilities.
The company relies on its good reputation, efficient management methods, excellent product quality, and has become the leader in the international market. The products meet the latest version standards of BP/EP/USP and other pharmacopoeias, which can meet the quality needs of global customers. The company has a professional international trade sales team that can provide the fastest feedback to domestic and foreign customers’ consultation audits and other requirements. The company’s products have been sold to dozens of countries and regions such as India, Pakistan, Indonesia, Philippines, Vietnam, Germany, Russia, Brazil, Chile, Africa, etc. It has established long-term good cooperative relations with internationally renowned formulation manufacturers of rifamycin series products at home and abroad.
Time flies by unconsciously. Hebei Xingang Pharmaceutical Co., Ltd. has gone through nearly 20 years. In these 20 years, Xingang Pharmaceutical has seized talents and every opportunity to gradually strengthen itself. At present, the company has become the leader in rifampicin API industry. It can be foreseen that the company’s products will have a broader market and the enterprise will enter a more benign cycle. On the road of production and development of rifamycin series products, Hebei Xingang Pharmaceutical Co., Ltd. will surely become a rising star.
Hebei Xingang Pharmaceutical Co., Ltd.
No.25 Zhaoyuan Road, Zhao County, Shijiazhuang. 051530 China Phone: +86-311-80889704, 80889705
%20in%20Shanghai.jpg)
%20in%20Shanghai.jpg)
